Digital diagnostics deals with a
common tool in which a person can easily collaborate across the entire
application lifecycle by allowing quick isolation and resolution of
issues. This new technology supports to progress in medical care system
by contributing in the precision and correctness of the diagnostics
output. Digital diagnostics categorizes, prioritizes and reports on
hitches. Digital diagnostics tracks regular scans through every inch of
your portfolio, from websites and widgets to social and mobile. The
process of digital diagnostics is now a common term for many medical
device applications, the installed software delivers deep drill down
into transactions from the end user through the back end. Digital
diagnostics makes use of unified tools to hold the entire classification
of medical device providers, consumers and healthcare professionals and
hence grades in enhanced care quality and access, improved patient
engagement, closing communication gaps, improved decision making by
consumers and medical device providers & reduction in healthcare
cost. Healthcare experts recommend that through digital diagnostics,
programmed health assessments can be carried out virtually and
electronically. The terrestrial barriers can be concentrated with this
technology by making it conceivable to diagnose patients placed away
from the diagnostic center and clinics.
The global digital diagnostics market is
segmented on the basis of product type, end users and region. The
product type include Oxitone, Cerora Borealis, Oto, Midmark IQvitals,
IQecg, IQholter, IQspiro and IQstress, Lifepatch, Intelligent Breast
Exam (iBE), Biomeme device, iBrain, Fever Smart, HealthPatch MD,
VitalPatch, BioStampRC, Qardioarm, Qardiobase, and Qardiocore, HxM BT,
HxM Smart, and BioHarness 3 and others. Currently, manufacturing
companies have established their individual mobile applications and
software programs to make remote diagnostics conceivable. During the
forecast period, it is projected that more cutting-edge high-end
programs will be produced by the companies to diagnose patients
irrespective of their physical existence in the diagnostic facility. The
integration of medical codes linked with healthcare informatics
software solutions requires additional IT investments. This IT trend
will attract numerous start-up vendors and medical outsourcing solutions
providers in the digital diagnostic market during the forecast period.
The U.S. is a major market for digital diagnostics services because of
advanced and improved healthcare IT infrastructure, launching reliable
healthcare data prototypes. Advancement in information & technology
and medical health applications, help minimize errors and heighten
working procedures.
The key mass drivers supporting the
market growth of digital diagnostics are growing awareness related to
daily health diagnostics, patients are expected to prefer digital
diagnostic over laboratory or hospital visit, and this technology
platform is estimated to surge the approachability for patients as well
as medical practitioners. Digital diagnostics market often depresses
entry barriers, causing established boundaries between sectors to
tumble. Moreover the nature of digital technology causes value chains to
disaggregate, generating opportunities for focused, fast-moving
entrants. New market competitors often scale up rapidly at lower cost
and returns may grow swiftly as more customers will connect to the
online network. Expertise technology companies like Google, Microsoft
& Apple are capitalizing significantly in this canvas. The initial
utilizers of digital tools are individuals or parents, people with
health issues and young adults. Even though still in its emerging stage,
digital diagnostics market seems to offer a mix of suitability,
customization, accessibility or simply the need to have a digital
device. For e.g. Accenture is now offering better software tools to
access the information from both the ends, such as from end user to the
physician directly within seconds. For healthier patient experience.
Information fed electronically or manually to mobile applications, such
as “Well Docs BlueStar”, is analysed to guide the individual and send
the synchronized data to their physician to track the progress. This
optimises time and treatment proficiencies.
Based on geography, the global digital
diagnostics market is segmented into five key regions, North America,
Europe, Asia Pacific, Latin America, and the Middle East and Africa.
North America is the leading regional market for digital diagnostics and
is trailed by Europe due to the existence of a large number of
population suffering with diseases, and high patient awareness related
to disease diagnosis in these regions. Some countries from Asia–Pacific
and Latin America are expected to enter the market late because of lack
of digital infrastructure, and accessibility to advanced technology.
However, rising healthcare expenditure, developing healthcare
infrastructure and increasing awareness related to the disease
diagnosis. However, poor healthcare facilities in underdeveloped and
emerging countries which lack appropriate healthcare infrastructure and
trained staff is anticipated to affect the adoption in these countries.
Some of the major players in the global
digital diagnostics market include Neurovigil, Inc., Oxitone Medical
Ltd., Cerora, CellScope, MidMark Corp., MC10, Inc., Qardio, Inc., Vital
Connect, Fever Smart, UE LifeSciences, Inc., Biomeme, Medtronic, Inc.
and others.
No comments:
Post a Comment